Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Systemair AB Interim Report Q3 2019/20

Press Release, March 11, 2020 Third quarter November 2019 – January 2020 · Net sales increased by 6.4 percent to SEK 2,147 million (2,018). · Organic growth was 1.8 percent (6.2). · Operating profit (EBIT) totalled SEK 113 million (80). · The operating margin was 5.2 percent (4.0). · Profit after tax amounted to SEK 64 million (45). · Earnings per share totalled SEK 1.20 (0.85). · Cash flow from operating activities amounted to SEK 288 million (189). Roland Kasper, President and CEO, comments: “During the third quarter, growth was recorded at 6.4 percent, of

Clifford Chance to present final report on Swedbank on 23 March, 2020

The international law firm Clifford Chance has, on behalf of the Board of Swedbank, analysed the bank’s work on anti-money laundering.The investigation includes customers, transactions and activities from 2007 through March 2019 and how the bank has handled internal and external information disclosures. Clifford Chance has also assessed Swedbank's historical response to previously identified deficiencies.  On 23 March, at 10:00 am CET, Clifford Chance will present its report at a press conference. Following the press conference, Chairman of the Board Göran Persson, and President and

Axactor Annual Report 2019

Oslo, March 11th 2020 Axactor has published its Annual Report for 1 January 2019 to 31 December 2019. The Financial Review, including the Report by the Board of Directors, Financial Statements and the Corporate Governance Statement, is also available on the company’s website www.axactor.com.  The Corporate Governance Statement has been prepared in accordance with the Norwegian Corporate Governance Code (NUES). Axactor’s Sustainability Report 2019 is integrated into the Annual Report.    For additional information, please contact:  Endre Rangnes, CEO, AxactorMobile phone:

Nixu Gamifies Cybersecurity Awareness – Serious Training Can Be Entertaining

Nixu Corporation, Press release, March 11, 2020, at 8:00 AM EETEuropean cybersecurity company Nixu is concerned about the growing level of phishing that can harm people from all walks of life and across all levels of society. Training has a great preventive effect as it helps people to effectively improve their social engineering awareness and identify and prevent phishing. As technologies and cyber defense protection continue to improve, criminals tend to exploit the human weaknesses of employees to gain easier access to an organization's information and systems. With a clever social

Clas Ohlsons nine-month report 2019/20

Improved profitabilityThird quarter – 1 November 2019 to 31 January 2020 · Sales in the Nordics increased by 2% to 2,883 MSEK (2,823), organic growth up 2% and total sales as well as organic growth were unchanged at 2,905 MSEK (2,915) · Online sales increased 19% to 177 MSEK (148) · Operating profit, including non-recurring costs and costs linked to the CO100+ action programme, totalled 378 MSEK (105). Excluding the effect of IFRS 16, operating profit amounted to 355 MSEK · Underlying operating profit amounted to 368 MSEK (363) (excl IFRS 16) · The operating margin was 13.0%

Targovax ASA: Annual Report 2019

On 10 March 2020, the Board of Directors of Targovax ASA approved the Company's financial statements for 2019, which will be processed at the Company's annual general meeting on 29 April 2020. The Company's annual accounts for the financial year 2019, including the financial statements and annual report for the financial year 2019, are together with the auditor's report attached to this notice. The documents are also available at the Company's website, www.targovax.com . Targovax Annual Report 2019 

Targovax ASA: Fourth quarter 2019 results

Oslo, Norway, 11 March 2020 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, today announces its fourth quarter 2019 results. A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET (details below). HIGHLIGHTS FOR THE FOURTH QUARTER 2019 · In October, Targovax was selected for oral presentation at Society for Immunotherapy of Cancer (SITC) 2019 Annual Meeting. The presentation was given by Dr. Alexander Shoushtari, Principal Investigator of ONCOS-102 trial in

Smart control of power plants to support the growth of renewable energy

The fluctuating supply of wind and solar energy forces traditional power plants to be more flexible. The two-year SmartFlex project develops smart monitoring and control tools that can be used to control power plants in rapidly changing situations. The aim is to extend the lifespan of the plants as well as to maintain high efficiency and low emissions in a reliable way.Conventional combined heat and power (CHP) production balances the fluctuation that wind and solar power bring to the energy market. CHP plants also provide an opportunity to combust biomass residues as well as waste, thus

BRAbank ASA: BRA-ME - Completion of private placement

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Bergen, 10 March 2020 Reference is made to the stock exchange announcement published on 5 March 2020 regarding launch of a private placement in BRAbank ASA ("BRAbank" or the "Company"). BRAbank announces that its Board of Directors has resolved to

Biovica provides updates on FDA application

Uppsala, Sweden, March 10, 2020. Biovica, active in cancer diagnostics, today announced that the company intends to submit an FDA application for market approval of DiviTum in the third quarter of 2020 and not as previously announced in mid-2020.“We are pleased with our results in the analytical validation, which is part of our FDA application and so far meet the criteria we have set. However, a component supplier has had delivery delays which means that we now anticipate being able to submit the FDA application a little later than previously expected,” said Anders Rylander, CEO of Biovica.

Norwegian Minister of Climate and Environment opened upgraded furnace at Elkem Bremanger

10 MARCH 2020: The Norwegian Minister of Climate and Environment, Sveinung Rotevatn, today opened the upgraded silicon furnace at Elkem Bremanger in Norway. The upgrade increases the plant’s cost efficiency and reduces NOx emissions with up to 50% – similar to removing 100.000 diesel cars from the road.Around NOK 250 million has been invested in the upgrade. The Norwegian NOx fund has supported the project with NOK 90 million. In addition to improving cost efficiency and cut NOx emissions, the project has additional benefits, when it comes to safety standards and work environment. “Elkem

Neste to acquire Mahoney Environmental to strengthen its growth strategy and position in renewable raw material sourcing

Neste Corporation, Press Release, 10 March 2020 at 9.55 p.m. (EET)  Neste, the world's leading producer of renewable diesel and sustainable aviation fuel produced from waste and residue raw materials, has agreed to acquire 100% of Mahoney Environmental (Mahoney), a collector and recycler of used cooking oil in the United States, and its affiliated entities. The transaction is subject to the fulfillment of customary closing conditions and regulatory approval. “This is another important step for Neste in the execution of our growth strategy. With this acquisition we will gain

Bong makes bond repurchase

Bong AB (publ) has made a repurchase of its own senior secured notes on the market. The repurchase was made to the nominal amount of SEK 10 million. The repurchase is related to the company’s own bond loan with an outstanding nominal amount before the repurchase of 210 MSEK which Bong issued in October 2018 with a 3 year tenure at the interest rate of Stibor (3m) +10 %. The senior secured notes are listed on Nasdaq Stockholm’s Corporate Bonds List with ISIN: SE0011281419. Bong is one of the leading providers of envelope products in Europe that also offers solutions for distribution

Cereno Scientific Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

Cereno Scientific today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to the company’s lead compound CS1, for the treatment of Pulmonary Arterial Hypertension (PAH). PAH is a form of high blood pressure in the lungs where the increased pressure is primarily caused by changes in the lung vessels.CS1 is a reformulation of valproic acid (VPA), an HDAC (Histone DeACetylase) inhibitor that acts as an epigenetic modulator with anti-thrombotic, anti-inflammatory, anti-fibrotic and pressure-relieving properties. These characteristics are a good match

Clarification of Intrum's exposure in Italy

In light of the Italian government's measures to stem the spread of the corona virus, we anticipate a delay of Intrum's cash flow in Italy. A large proportion of this cash flow is related to secured assets, almost exclusively real estate, that are typically processed through the Italian court system. The absolute majority of Intrum's operations in Italy consists of the partnership with Intesa Sanpaolo, where Intrum owns 51 percent, and a debt portfolio owned through a SPV together with Intesa Sanpaolo, where Intrum owns 41 per cent. The combined contribution in 2019 was approximately 4

Episurf Medical publishes prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, THE UNITED KINGDOM, JAPAN, NEW ZEALAND, SINGAPORE, SWITZERLAND, SOUTH AFRICA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFULThe Board of Directors of Episurf Medical AB (publ) ("Episurf Medical" or "the Company") publishes a prospectus on the basis of the rights issue of shares (the "Rights Issue") resolved by the Extraordinary General Meeting held on March 10, 2020. The prospectus has today been approved and

EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.03.2020

EAB GROUP PLC NOTIFICATION 10.03.2020 at 18:30 EAB GROUP PLC: ACQUISITION OF OWN SHARES 10.03.2020   Date 10.03.2020  Exchange transaction Buy  Share class EAB  Amount 496  Average price/share 2.5400 EURHighest price/share 2.5400 EURLowest price/share 2.5400 EURTotal price 1,259.84 EUR      The shares held by EAB Group Plc on 10.03.2020:   EAB 15,931     On behalf of EAB Group Plc  Skandinaviska Enskilda Banken

United Bankers Corporation: Acquisition of Own Shares 10.03.2020

United Bankers Corporation NOTIFICATION   10.03.2020 at 18:30   UNITED BANKERS CORPORATION: ACQUISITION OF OWN SHARES 10.03.2020 Date 10.03.2020Exchange transaction BuyShare class UNIAVAmount 300Average price/share 8.7000 EURHighest price/share 8.7000 EURLowest price/share 8.7000 EURTotal price 2,610.00 EUR The shares held by United Bankers Corporation on 10.03.2020: UNIAV 33,587 On behalf of United Bankers CorporationSkandinaviska Enskilda Banken AB (Publ)   Antti

Notification of Trade

Geveran Trading Co. Limited (“Geveran”), a company indirectly controlled by trusts established by Mr. John Fredriksen for the benefit of his immediate family, has on 10 March 2020 acquired 135,000 shares in Flex LNG Ltd (“Flex LNG”) at a purchase price of NOK 50.1465 per share. Following the acquisition, Geveran will own 24,678,811 shares in Flex LNG which will constitute 45.61% of the shares and votes in Flex LNG. Geveran controls in addition TRS agreements with exposure to totally 825,000 shares in Flex LNG Ltd. The foregoing calculations are based on 54,110,584 outstanding shares in Flex

Norwegian Energy Company ASA: Share buyback

Reference is made to the stock market announcement on 27 February 2020, where Norwegian Energy Company ASA ("Noreco" or the "Company") announced an initiation of a share buyback programme of up to 160,000 of its own shares. Noreco has on 10 March 2020 purchased 9,992 of its own shares at an average price of NOK 143.3800 per share. After this transaction the Company holds a total of 320,782 own shares. The transaction is completed in accordance with the authorization given by Noreco's annual general meeting on 28 June 2018, which is valid until 28 June 2020. The information is

#20-86 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details see attached file. For further information concerning this NGM notice please contact: Listing on +46 8 566 390 20 or at listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

There are no items matching the current filter
There are no more items matching the current filter
Back to top